NIR‐Responsive Plasmonic PtSb Alloys with Strong p‐d Orbital Hybridization for Synergistic Photothermal‐Catalytic Therapy
Developing platinum (Pt)-based nanostructures with strong near-infrared (NIR) plasmonic response and catalytic activity remains challenging for efficient photothermal-catalytic therapy, due to their poor optical tunability in the NIR region. Here, orbital-engineered PtSb nanoalloys are reported that exhibit broadband NIR plasmonic resonance and enhanced peroxidase (POD)-like activity, driven by strong p-d orbital hybridization between Pt and Sb. Finite-difference time-domain simulations further confirm the presence of localized surface plasmon resonance and enhanced electromagnetic field distribution in PtSb nanocrystals (NCs). The optimized Pt<sub>84</sub>Sb<sub>16</sub> NCs demonstrate high NIR photothermal conversion efficiency and augmented POD-like catalytic activity, enabling synergistic reactive oxygen species (ROS) amplification and thermal ablation. In vitro and in vivo studies confirm that NIR-activated PtSb NCs induce robust apoptosis and immunogenic cell death, achieving potent therapeutic efficacy in breast cancer models. This work offers a promising strategy for engineering unconventional Pt-based plasmonic nanoalloys and expands their potential in photothermal-catalytic cancer therapy.
Authors
- Guchun Qin
- Junjie Zhou
- Wenxin Niu (ORCID: https://orcid.org/0000-0002-0835-3295)
- Jinping Wei
- Weiqing Zhang (ORCID: https://orcid.org/0000-0002-1324-2944)
- Yanping Tang (ORCID: https://orcid.org/0000-0003-4947-1762)
- Dan Li (ORCID: https://orcid.org/0000-0001-5904-871X)
- Yu Tian (ORCID: https://orcid.org/0009-0002-3937-2314)
- Fengxia Wu (ORCID: https://orcid.org/0000-0001-7769-5101)
- Chang Zhao
Institutions
- University of Science and Technology of China (CN)
- Guangxi Medical University (CN)
- Changchun Institute of Applied Chemistry (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Small
- Published
- 2025-08-19
- DOI
- https://doi.org/10.1002/smll.202506890
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67
Funders
- National Natural Science Foundation of China